Clinical Trial Update: Study to Evaluate the Tolerability, Safety, Pharmacokinetics and Pharmacodynamics of TQA3810 Tablets [Phase 1]

View source ↗

Summary

Phase 1 clinical trial completed evaluating tolerability, safety, pharmacokinetics and pharmacodynamics of TQA3810 tablets in Chronic Hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• TQA3810

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Chronic Hepatitis B | Phase 1 | Status: COMPLETED